New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

FHS
April 5, 2024
9:57 am

The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Quarterly / Interim Statement/Preliminary Results Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year;

July 16, 2024

Blocking CDK7 protein could prevent heart damage associated with cancer treatment

Blocking a protein known as CDK7 could prevent heart damage associated with a commonly used cancer chemotherapy medication, according to a study led by scientists

June 4, 2024

Rocket shares promising long-term results from rare heart disease gene therapy in small study

Rocket Pharmaceuticals reported Monday that benefits from its Danon disease gene therapy were seen up to around five years after treatment. The Cranbury, NJ-based biotech

November 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.